Daniel Poloske
Vienna, Austria
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
Thyroid hormone receptor beta signaling is a targetable driver of prostate cancer growth.
Journal: Molecular cancer
Published: April 14, 2025
Monoselective Histone Deacetylase 6 PROTAC Degrader Shows In Vivo Tractability.
Journal: Journal of medicinal chemistry
Published: March 10, 2025
Multiomics Profiling of T-cell Leukemia and Lymphoma Enables Targeted Therapeutic Discovery.
Journal: Cancer research
Published: February 27, 2025
Electrophilic MiniFrags Revealed Unprecedented Binding Sites for Covalent HDAC8 Inhibitors.
Journal: Journal of medicinal chemistry
Published: December 19, 2023
Hyperactive STAT5 hijacks T cell receptor signaling and drives immature T cell acute lymphoblastic leukemia.
Journal: The Journal of clinical investigation
Published: January 04, 2023
High Efficacy and Drug Synergy of HDAC6-Selective Inhibitor NN-429 in Natural Killer (NK)/T-Cell Lymphoma.
Journal: Pharmaceuticals (Basel, Switzerland)
Published: August 16, 2022
Blocking STAT3/5 through direct or upstream kinase targeting in leukemic cutaneous T-cell lymphoma.
Journal: EMBO molecular medicine
Published: September 28, 2021
Efficacy and Synergy of Small Molecule Inhibitors Targeting FLT3-ITD+ Acute Myeloid Leukemia.
Journal: Cancers
Published: August 27, 2021
Showing 1-11 of 11
Last Updated: 09/26/2026